Note 13 - Segment Reporting and Geographic Information - Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Clinical and pre-clinical expenses | $ 676 | $ 428 | $ 1,742 | $ 720 | ||||
| Patent expenses | 92 | 169 | 302 | 644 | ||||
| Personnel costs | 512 | 562 | 1,662 | 2,148 | ||||
| Professional services | 569 | 233 | 1,398 | 1,587 | ||||
| Other operational expenses | 214 | 248 | 641 | 756 | ||||
| Other segment items | 1 | (18) | (9) | (69) | ||||
| Segment net loss | 2,064 | 1,622 | 5,736 | 5,786 | ||||
| Net loss (income) from discontinued operations | (52,556) | 3,322 | (43,854) | 2,637 | ||||
| Consolidated net loss | $ (50,492) | $ 5,700 | $ 6,674 | $ 4,944 | $ 4,649 | $ (1,170) | $ (38,118) | $ 8,423 |
| X | ||||||||||
- Definition The amount of clinical and pre-clinical expenses. No definition available.
|
| X | ||||||||||
- Definition The amount of patent expenses. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|